Leah M Smith1, Jay S Kaufman2, Erin C Strumpf2, Linda E Lévesque2. 1. Department of Epidemiology, Biostatistics, and Occupational Health (Smith, Kaufman, Strumpf), McGill University, Montréal, Que.; Department of Public Health Sciences (Lévesque), Queen's University, Kingston, Ont. leah.smith3@mail.mcgill.ca. 2. Department of Epidemiology, Biostatistics, and Occupational Health (Smith, Kaufman, Strumpf), McGill University, Montréal, Que.; Department of Public Health Sciences (Lévesque), Queen's University, Kingston, Ont.
Abstract
BACKGROUND: Suboptimal human papillomavirus (HPV) vaccine coverage in some jurisdictions is partly attributed to fears that vaccination may increase risky sexual behaviour. We assessed the effect of HPV vaccination on clinical indicators of sexual behaviour among adolescent girls in Ontario. METHODS: Using Ontario's administrative health databases, we identified a population-based cohort of girls in grade 8 in the 2 years before (2005/06 and 2006/07) and after (2007/08 and 2008/09) implementation of Ontario's grade 8 HPV vaccination program. For each girl, we then obtained data on vaccine receipt in grades 8 and 9 and data on indicators of sexual behaviour (pregnancy and non-HPV-related sexually transmitted infections) in grades 10-12. Using a quasi-experimental method known as regression discontinuity, we estimated, for each outcome, the risk difference (RD) and relative risk (RR) attributable to vaccination and to program eligibility. RESULTS: The cohort comprised 260 493 girls, of whom 131 781 were ineligible for the program and 128 712 were eligible. We identified 15 441 (5.9%) cases of pregnancy and sexually transmitted infection and found no evidence that vaccination increased the risk of this composite outcome: RD per 1000 girls -0.61 (95% confidence interval [CI] -10.71 to 9.49) and RR 0.96 (95% CI 0.81 to 1.14). Similarly, we found no discernible effect of program eligibility: RD per 1000 girls -0.25 (95% CI -4.35 to 3.85) and RR 0.99 (95% CI 0.93 to 1.06). The findings were similar when outcomes were assessed separately. INTERPRETATION: We present strong evidence that HPV vaccination does not have any significant effect on clinical indicators of sexual behaviour among adolescent girls. These results suggest that concerns over increased promiscuity following HPV vaccination are unwarranted and should not deter from vaccinating at a young age.
BACKGROUND: Suboptimal human papillomavirus (HPV) vaccine coverage in some jurisdictions is partly attributed to fears that vaccination may increase risky sexual behaviour. We assessed the effect of HPV vaccination on clinical indicators of sexual behaviour among adolescent girls in Ontario. METHODS: Using Ontario's administrative health databases, we identified a population-based cohort of girls in grade 8 in the 2 years before (2005/06 and 2006/07) and after (2007/08 and 2008/09) implementation of Ontario's grade 8 HPV vaccination program. For each girl, we then obtained data on vaccine receipt in grades 8 and 9 and data on indicators of sexual behaviour (pregnancy and non-HPV-related sexually transmitted infections) in grades 10-12. Using a quasi-experimental method known as regression discontinuity, we estimated, for each outcome, the risk difference (RD) and relative risk (RR) attributable to vaccination and to program eligibility. RESULTS: The cohort comprised 260 493 girls, of whom 131 781 were ineligible for the program and 128 712 were eligible. We identified 15 441 (5.9%) cases of pregnancy and sexually transmitted infection and found no evidence that vaccination increased the risk of this composite outcome: RD per 1000 girls -0.61 (95% confidence interval [CI] -10.71 to 9.49) and RR 0.96 (95% CI 0.81 to 1.14). Similarly, we found no discernible effect of program eligibility: RD per 1000 girls -0.25 (95% CI -4.35 to 3.85) and RR 0.99 (95% CI 0.93 to 1.06). The findings were similar when outcomes were assessed separately. INTERPRETATION: We present strong evidence that HPV vaccination does not have any significant effect on clinical indicators of sexual behaviour among adolescent girls. These results suggest that concerns over increased promiscuity following HPV vaccination are unwarranted and should not deter from vaccinating at a young age.
Authors: Marion Haas; Toni Ashton; Kerstin Blum; Terkel Christiansen; Elena Conis; Luca Crivelli; Meng Kin Lim; Melanie Lisac; Margaret Macadam; Sophia Schlette Journal: Health Policy Date: 2009-06-07 Impact factor: 2.980
Authors: Tanya L Kowalczyk Mullins; Gregory D Zimet; Susan L Rosenthal; Charlene Morrow; Lili Ding; Marcia Shew; J Dennis Fortenberry; David I Bernstein; Jessica A Kahn Journal: Arch Pediatr Adolesc Med Date: 2012-01
Authors: Susan L Rosenthal; Richard Rupp; Gregory D Zimet; Heather M Meza; Melissa L Loza; Mary B Short; Paul A Succop Journal: J Adolesc Health Date: 2008-09 Impact factor: 5.012
Authors: Michael R Law; Lucy Cheng; Heather Worthington; Muhammad Mamdani; Kimberlyn M McGrail; Fiona K I Chan; Sumit R Majumdar Journal: CMAJ Date: 2017-05-15 Impact factor: 8.262
Authors: Alex Vorsters; Marc Arbyn; Marc Baay; Xavier Bosch; Silvia de Sanjosé; Sharon Hanley; Emilie Karafillakis; Pier Luigi Lopalco; Kevin G Pollock; Joanne Yarwood; Pierre Van Damme Journal: Papillomavirus Res Date: 2017-07-20
Authors: Erin Y Liu; Leah M Smith; Anne K Ellis; Heather Whitaker; Barbara Law; Jeffrey C Kwong; Paddy Farrington; Linda E Lévesque Journal: CMAJ Date: 2018-05-28 Impact factor: 8.262
Authors: Gina S Ogilvie; Felicia Phan; Heather N Pedersen; Simon R Dobson; Monika Naus; Elizabeth M Saewyc Journal: CMAJ Date: 2018-10-15 Impact factor: 8.262
Authors: Lisa N Mansfield; Elijah O Onsomu; Elizabeth Merwin; Naomi M Hall; Alfreda Harper-Harrison Journal: West J Nurs Res Date: 2016-12-01 Impact factor: 1.967
Authors: Tanya L Kowalczyk Mullins; Gregory D Zimet; Susan L Rosenthal; Charlene Morrow; Lili Ding; Bin Huang; Jessica A Kahn Journal: Vaccine Date: 2016-06-10 Impact factor: 3.641
Authors: Robine Donken; Gina S Ogilvie; Julie A Bettinger; Manish Sadarangani; Ran D Goldman Journal: Can Fam Physician Date: 2018-07 Impact factor: 3.275